Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures

Molecular Nutrition and Food Research

Volumn 57, Issue 2, 2013, Pages 235-248

  Parasramka, Mansi A ^a   Ali, Shadan ^b   Banerjee, Sanjeev ^b   Deryavoush, Tara ^a   Sarkar, Fazlul H ^b   Gupta, Smitiv ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemosensitization; Garcinol; Gemcitabine; MicroRNA; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; CASPASE; DEOXYCYTIDINE; DRUG DERIVATIVE; GARCINOL; GELATINASE B; GEMCITABINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MICRORNA; MMP9 PROTEIN, HUMAN; TERPENE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; PANCREAS TUMOR; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING; WOUND HEALING;

ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DEOXYCYTIDINE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; INTERLEUKIN-8; MATRIX METALLOPROTEINASE 9; MICROARRAY ANALYSIS; MICRORNAS; NF-KAPPA B; PANCREATIC NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION; TERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

AGOUTI PACA;

EID: 84872787049     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200297     Document Type: Article

References (41)

1. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics, 2012. CA Cancer. J. Clin. 2012, 62, 10-29.
2. Moore, P. S., Beghelli, S., Zamboni, G., Scarpa, A., Genetic abnormalities in pancreatic cancer. Mol. Cancer 2003, 2, 7.
3. Parasramka, M. A., Gupta, S. V., Garcinol inhibits cell proliferation and promotes apoptosis in pancreatic adenocarcinoma cells. Nutr. Cancer 2011, 63, 456-465.
4. Ahmad, A., Wang, Z., Wojewoda, C., Ali, R. et al., Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF-KappaB signaling. Front Biosci. (Elite Ed) 2011, 3, 1483-1492.
5. Azmi, A. S., Beck, F. W., Bao, B., Mohammad, R. M. et al., Aberrant epigenetic grooming of miRNAs in pancreatic cancer: a systems biology perspective. Epigenomics 2011, 3, 747-759.
6. Matthaios, D., Zarogoulidis, P., Balgouranidou, I., Chatzaki, E. et al., Molecular pathogenesis of pancreatic cancer and clinical perspectives. Oncology 2011, 81, 259-272.
7. Singh, P. K., Brand, R. E., Mehla, K., MicroRNAs in pancreatic cancer metabolism. Nat. Rev. Gastroenterol. Hepatol. 2012.
8. Parasramka, M. A., Ho, E., Williams, D. E., Dashwood, R. H., MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol. Carcinog. 2012, 51, 213-230.
9. Parasramka, M. A., Dashwood, W. M., Wang, R., Abdelli, A. et al., MicroRNA profiling of carcinogen-induced rat colon tumors and the influence of dietary spinach. Mol. Nutr. Food Res. 2012, 56, 1259-1269.
10. Davidson, L. A., Wang, N., Shah, M. S., Lupton, J. R. et al., n-3 Polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 2009, 30, 2077-2084.
11. Shah, M. S., Schwartz, S. L., Zhao, C., Davidson, L. A. et al., Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiol. Genomics 2011, 43, 640-654.
12. Angel-Morales, G., Noratto, G., Mertens-Talcott, S., Red wine polyphenolics reduce the expression of inflammation markers in human colon-derived CCD-18Co myofibroblast cells: potential role of microRNA-126. Food Funct. 2012, 3, 745-752.
13. Chou, T. C., Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010, 70, 440-446.
14. Parasramka, M. A., Gupta, S. V., Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells. J. Oncol. 2012, 2012, 709739.
15. Izzotti, A., Larghero, P., Cartiglia, C., Longobardi, M. et al., Modulation of microRNA expression by budesonide, phenethyl isothiocynate and cigarette smoke in mouse liver and lung. Carcinogenesis 2010, 31, 894-901.
16. Ali, S., Banerjee, S., Ahmad, A., El-Rayes, B. F. et al., Apoptosis-inducing effect of erlotinib is potentiated by 3, 3'-diindolylmethane in vitro and in vivo using an orthotopic model of pancreatic cancer. Mol. Cancer Ther. 2008, 7, 1708-1719.
17. Chaturvedi, M. M., Mukhopadhyay, A., Aggarwal, B. B., Assay for redox-sensitive transcription factor. Methods Enzymol. 2000, 319, 585-602.
18. Giovannetti, E., Funel, N., Peters, G. J., Del Chiaro, M. et al., MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res. 2010, 70, 4528-4538.
19. Zhang, Y., Li, M., Wang, H., Fisher, W. E. et al., Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J. Surg. 2009, 33, 698-709.
20. Ren, Y. X., Xu, G. M., Li, Z. S., Song, Y. G., Detection of point mutation in K-ras oncogene at codon 12 in pancreatic diseases. World J. Gastroenterol. 2004, 10, 881-884.
21. Dacic, S., Shuai, Y., Yousem, S., Ohori, P. et al., Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinoma. Mod. Pathol. 2010, 23, 159-168.
22. Guo, J., Miao, Y., Xiao, B., Huan, R. et al., Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol. 2009, 24, 652-657.
23. Lee, I., Ajay, S. S., Yook, J. I., Kim, H. S. et al., New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res. 2009, 19, 1175-1183.
24. Tchatchou, S., Jung, A., Hemminki, K., Sutter, C. et al., A variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal women. Carcinogenesis 2009, 30, 59-64.
25. Smith, B. D., Smith, G. L., Hurria, A., Hortobagyi, G. N., et al., Future of cancer incidence in the United States: burdens upon an aging, changing nation. J. Clin. Oncol. 2009, 27, 2758-2765.
26. Zhang, L., Jamaluddin, M. S., Weakley, S. M., Yao, Q., et al., Roles and mechanisms of microRNAs in pancreatic cancer. World J. Surg. 2011, 35, 1725-1731.
27. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S. et al., A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432, 226-230.
28. Hwang, J. H., Voortman, J., Giovannetti, E., Steinberg, S. M. et al., Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One 2010, 5, e10630.
29. Moriyama, T., Ohuchida, K., Mizumoto, K., Yu, J. et al., MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol. Cancer Ther. 2009, 8, 1067-1074.
30. Zheng, T., Wang, J., Chen, X., Liu, L., Role of microRNA in anticancer drug resistance. Int. J. Cancer 2010, 126, 2-10.
31. Sarkar, F. H., Li, Y., Wang, Z., Kong, D. et al., Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat. 2010, 13, 57-66.
32. Li, Y., VandenBoom, T. G., 2nd, Kong, D., Wang, Z. et al., Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Cancer Res. 2009, 69, 6704-6712.
33. Yekta, S., Tabin, C. J., Bartel, D. P., MicroRNAs in the Hox network: an apparent link to posterior prevalence. Nat. Rev. Genet. 2008, 9, 789-796.
34. Schimanski, C. C., Frerichs, K., Rahman, F., Berger, M. et al., High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J. Gastroenterol. 2009, 15, 2089-2096.
35. Ueda, T., Volinia, S., Okumura, H., Shimizu, M. et al., Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010, 11, 136-146.
36. Gusev, Y., Schmittgen, T. D., Lerner, M., Postier, R. et al., Computational analysis of biological functions and pathways collectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics 2007, 8 (Suppl 7), S16.
37. Sun, M., Estrov, Z., Ji, Y., Coombes, K. R. et al., Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 2008, 7, 464-473.
38. Tsuzuki, Y., Mouta Carreira, C., Bockhorn, M., Xu, L. et al., Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab. Invest. 2001, 81, 1439-1451.
39. Zhang, Y., Chen, C., Yao, Q., Li, M., ZIP4 upregulates the expression of neuropilin-1, vasular endothelial growth factor, and matrix metalloproteases in pancreatic cancer cell lines and xenografts. Cancer Biol. Ther. 2010, 9, 236-242.
40. Bausch, D., Pausch, T., Krauss, T., Hopt, U. T. et al., Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenci switch in pancreatic ductal adenocarcinoma. Angiogenesis 2011, 14, 235-243.
41. Kuwada, Y., Sasaki, T., Morinaka, K., Kitadai, Y. et al., Potential involvement of IL-8 and its receptors in the invasiveness of pancreatic cancer cells. Int. J. Oncol. 2003, 22, 765-771.